Screening for Chlamydia trachomatis was done for 280 endocervical swab samples by PCR specific for endogenous plasmid. Age dependency was seen in symptomatic patients, with a high chlamydial prevalence rate (28%) found in younger women. Genotyping by restriction fragment length polymorphism analysis of omp1 PCR-positive samples showed serovars D, E, and F to be the most prevalent.
AAC TCT ACG TCG) generated a fragment of 517 bp in the C. trachomatis-positive samples. The omp1 gene was amplified by primers selected from the published sequences of the omp1 gene of C. trachomatis (L 2 ) (21) . The PCR mixture contained 25 pmol of each of the forward and reverse primers, 200 M concentrations of each of the deoxynucleoside triphosphates (dATP, dTTP, dGTP, and dCTP), 10ϫ PCR buffer (containing 10 mM Tris HCl [pH 8.3] , 50 mM KCl, 2.5 mM MgCl 2 , 0.01% gelatin), and 0.1 U of Taq DNA polymerase (Gibco-BRL). PCR was performed in a thermocycler as follows: 5 min at 95°C; 40 cycles each consisting of denaturation at 94°C for 1 min, annealing at 60°C for 1 min, and extension at 72°C for 2 min; and a final elongation step of 10 min at 72°C. Restriction endonuclease digestion was performed with the restriction enzymes AluI, CfoI, HinfI, DdeI, and EcoRI (Promega, Madison, Wis.) on 5-l amounts of the amplified 871-bp PCR products by following the manufacturer's instructions.
All samples shown positive by the ␤-globin PCR assay were further screened by a plasmid PCR specific for the C. trachomatis endogenous plasmid. A clear age dependency was observed, showing a high prevalence rate among younger women. The overall prevalence rates of C. trachomatis in cervical swabs as determined by plasmid PCR were 28.5% in group I (age, 18 to 25 years), 7.6% in group II (age, 25 to 35 years), and 3.2% in group III (age, 35 to 45 years). C. trachomatis-positive swabs detected by plasmid PCR were further examined by omp1 PCR for genotyping by restriction fragment length polymorphism. Purified PCR products were digested with AluI to differentiate serovars of C. trachomatis (Fig. 1) . Serovars D and E showed fragments varying from 244 to 91 bp in size. Serovars B and D had a closely related pattern, except for the presence (serovar B) or absence (serovar D) of a 91-bp band in the digestion profile with AluI. The standard serovar F showed fragment sizes of 321 to 80 bp after digestion. Standard serovars L 3 and I, which are in the C complex, showed fragment of sizes 486 to 92 bp after digestion with AluI.
Serovars H, L 3 , and I were further distinguished by enzyme digestion with EcoRI and DdeI. With EcoRI, serovar I gave two bands, whereas with DdeI, it gave four bands varying between 323 to 80 bp in size. The clinical samples which were identified as having banding patterns matching that of serovar D after digestion with the AluI enzyme were further differen-tiated by digesting them with CfoI restriction enzyme. After analysis with the CfoI restriction enzyme, clinical samples were identified as serovar D, since they had an identical banding pattern as that of the standard serovar D. The restriction endonuclease sites for the various restriction enzymes are listed in Table 1 .
C. trachomatis serovar D (48%) was found to be the most prevalent, followed by serovars E (34%), F (12%), and I (6%) in urogenital samples.
The present study demonstrated that the prevalence of symptomatic C. trachomatis infection is high in cervical swabs, as determined by a sensitive PCR assay, and is age dependent. These data are in agreement with earlier published reports showing high C. trachomatis rates (6, 10) . The clinical samples could be discriminated by restriction endonuclease digestion with AluI. However, for a few clinical samples, digestion with HinfI, DdeI, CfoI, and EcoRI was done, which further aided in discriminating among C. trachomatis serovars.
In our study, serovar D (48%) was found to be the most prevalent serovar, followed by serovars E (34%), F (12%), and I (6%) in the urogenital samples. A similar distribution of C. trachomatis serovars has been reported earlier with tissue culture isolates (11) . This pattern of serovar prevalence was found to be in accordance with the distribution of C. trachomatis serovars in other regions of the world (4, 7, 8, 9 ). We were not able to find other serovars J, H, K, or G of C. trachomatis, which have been reported by few workers (1, 3, 12) . We did not observe any restriction endonuclease pattern different from the prototype or known variant strains in the 50 clinical samples examined. But this would have not been surprising, as others have found only a limited number of variants by serologic methods. In conclusion, C. trachomatis genotyping in women younger than age 30 years revealed that serovars D and E were more frequently found in symptomatic patients. The procedure we have used for cervical swabs by PCR restriction fragment length polymorphism analysis should enable basic serovar identification and provide a springboard for studies of variation. 
